Overview
As a critical tumor suppressor gene in humans, TP53 not only prevents tumor cell division and induces tumor cell apoptosis but also repairs DNA damage in normal cells. By detecting TP53 genotypes, this test can assess an individual's genetic predisposition to cancer, provide personalized guidance, and help reduce the risk of cancer development. Therefore, this product targets the CDS region of the TP53 gene and uses multiplex amplicon sequencing technology combined with NGS (next-generation sequencing) to enable efficient, convenient, and rapid detection of TP53 gene mutations.